Management of Pain Possible for Childhood Vaccinations

Published Online: Thursday, August 16, 2012
Follow Pharmacy_Times:
Pain associated with childhood vaccination is currently undertreated, even though there are number of pain-relieving strategies that could be employed. Many health care providers argue, however, that they are currently too pressed for time to implement these strategies.

To determine whether there was enough time available for pain management within each vaccination appointment, researchers at the University of Toronto conducted a prospective naturalistic study at 8 urban outpatient primary care clinics and published their results in the March-April 2012 edition of the Clinical Journal of Pain. The researchers tracked the waiting time of children in 405 appointments from clinic arrival to first vaccine administered.

Their results showed that the mean wait time until first vaccination was 41.6 minutes, with a range from 7 to 132 minutes. There was a statistically significant difference among the clinics for wait times, which explains the wide range of data. These results suggest that, contrary to the perception of some health care providers, there is adequate time available to implement pain management strategies for children undergoing vaccination.

The researchers note that health care providers and parents should be educated regarding the benefits of pain management interventions and how to put evidence-based strategies into practice.

To read more articles in this watch, click:
Muscle Relaxants in Rheumatoid Arthritis
Self-Management Demonstrated in Migraine Patients


Related Articles
In light of new data that shows the 2014-2015 flu season could be severe, the US Centers for Disease Control and Prevention is urging immediate influenza vaccination for all unvaccinated individuals, as well as prompt antiviral drug treatment for those who develop flu and have a high risk of complications.
A powdered measles vaccine delivered by a puff of air triggered no adverse side effects during early human testing, and future clinical trials will likely establish its efficacy.
A diverse collective of health care advocacy groups, patient organizations, industry representatives and other stakeholders today announced they have established the Alliance for Balanced Pain Management to support appropriate access to integrated pain management and responsible use of prescription pain medicines with an aim to reduce abuse. AfBPM will work collaboratively to educate, support and advocate on behalf of people affected by pain, both acute and chronic.
The first and only FDA-approved vaccine for active immunization to prevent invasive serogroup B meningococcal disease in patients aged 10 to 25 years is now available for order by retail pharmacies.
Latest Issues
$auto_registration$